- UNITED STATES
Dr W. Marston Linehan is Surgeon-in-Chief, National Institutes of Health and Chief of the Urologic Oncology Branch at the National Cancer Institute, National Institutes of Health, Bethesda, Maryland. After completing his internship, residency and fellowship training Duke University Medical Center he began his career at the National Cancer Institute in 1982 with positions as Senior Investigator and Urologist-in-Charge, NCI.
He has had a long-standing interest in identification of the genetic basis of kidney cancer. By studying patients and families with kidney cancer, he and his colleagues identified the VHL gene (von Hippel-Lindau and clear cell renal carcinoma), the gene for Hereditary Papillary Renal Carcinoma (MET oncogene, type I papillary renal carcinoma) the FLCN gene (Birt Hogg Dubé syndrome, chromophobe renal carcinoma), the gene for TFE3 kidney cancer and described the germline fumarate hydratase and succinate dehydrogenase B/C/D mutations in the North American families with hereditary leiomyomatosis renal cell carcinoma (HLRCC) and SDH-RCC and described five new diseases. This work has provided the basis for the development of new therapeutic strategies for the different types of kidney cancer based on understanding the molecular pathway of the specific cancer genes associated with the different types of kidney cancer. He defined the methods for clinical management of kidney cancer associated with the hereditary forms of kidney cancer, von Hippel Lindau, Hereditary Papillary Renal Carcinoma and Birt Hogg Dubé syndrome and Hereditary Leiomyomatosis Renal Cell Carcinoma and Succinate Dehydrogenase Renal Cell Carcinoma.
Dr Linehan is a member of the National Academy of Medicine. He has received the Gold Cystoscope Award, the Distinguished Contribution Award and the Ramon Guiteras Award from the American Urological Association, the Huggins Medal and the SUO Medal from the Society of Urologic Oncology and the Barringer Medal from the American Association of Genitourinary Surgeons.
Dr Luc Valiquette is a Urology Surgery Specialist at the Centre Hospitalier de l’Université de Montréal (CHUM). He specializes in investigation and treatment of benign prostatic hypertrophy, urinary stones, urinary incontinence and erectile dysfunction. Dr Valiquette did his urology training at Université de Montréal (U de M). After his training, he completed a Fellowship in urodynamics in Nantes (France, 1984) and one in uroprosthetic surgery and endourology in Houston (USA, 1985).
Dr Valiquette is Professor at the Department of Surgery of the Université de Montréal. He teaches surgery and urology at both pre- and post-graduate levels. He has been Program Director for urology training, and member of the accreditation committee at the Royal College of Physicians and Surgeons of Canada. He has been involved in numerous clinical research studies, many of which relate to the pharmacological and surgical treatment of BPH, urinary incontinence, overactive bladder, erectile dysfunction, urinary stones, and also medical informatics. Dr Valiquette has over 200 scientific papers, summaries, and book chapters to his credit. He is a member of many scientific societies.
Dr Valiquette has chaired, or been a member of, organizing committees for more than twenty national or international urology meetings. He was also Head of the Division of Urology and Chair of Surgery at U de Montréal. He is a past President of the Quebec Urological Association and the Canadian Urological Association. He sits on advisory boards of pharmaceutical and medical device companies, as well as not-for-profit societies.
He has been involved with the SIU since 1991, first as a member of the planning committee and local organizing committee for the 1997 meeting in Montreal. He was also the Canadian National Delegate from 1997 to 2003 and took on the role of adjunct General Secretary when the central office moved to Montreal in 1999. Dr Valiquette was a member of the congress organizing committees for the Singapore meeting in 2000 and became Chairman of the SIU Congress Organizing Committee for the Stockholm (2002), Hawaii (2004) and Cape Town (2006) meetings. Dr Valiquette served as SIU General Secretary from 2006 until 2011, and was elected SIU President in 2013. During this time, he worked closely with Dr Mostafa Elhilali and other members of the SIU executive to develop the society into a global organization with annual meetings and global educational and philanthropic initiatives.
- UNITED STATES
Dr Joseph A Smith, Jr. is William L. Bray Professor in the Department of Urologic Surgery at Vanderbilt University in Nashville, Tennessee. He served as Chairman of the department from 1991 to 2015. He is an AOA graduate of the University of Tennessee Medical School and was named its Outstanding Graduate. He completed his surgery residency at the University of Texas Southwestern Medical School at Dallas, his urology residency at the University of Utah, and a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York.
Dr Smith has served as President of the American Board of Urology, the Society of Urologic Oncology, and the Southeastern Section of the AUA, and as Chairman of the Residency Review Committee for Urology. He is a recipient of the Distinguished Contribution Award and the Hugh Hampton Young Award from the AUA, and the SUO achievement medal and the Huggins Medal from the Society of Urologic Oncology.
He is a member of the American Association of Genitourinary Surgeons and the Clinical Society of GU Surgeons. He was awarded the Outstanding Alumnus Award from the University of Tennessee. Dr Smith is Editor of the Journal of Urology, the most widely-read and highly-cited journal in the specialty. He has been listed on Castle Connelly prestigious “Best Doctors” list for 25 consecutive years and was designated by Time Magazine as one of the top five surgeons in the country for treatment of cancer.
He has published over 300 peer-reviewed manuscripts, over 100 book chapters, and has edited or co-edited eight textbooks including the third edition of Hinman’s Atlas of Urologic Surgery. His professional focus has been on innovative treatment strategies for patients with urologic cancers and introduction and evaluation of technologic advances in urologic surgery. He has performed over 1,000 radical cystectomies and 7,000 radical prostatectomies.
- UNITED STATES
Dr Paul Lange is Professor Emeritus of the Department of Urology at University of Washington in Seattle, where he served as chair for 19 years. He received his medical degree from Washington University Medical School. He subsequently received residency, fellowship and research training at the National Institutes of Health, Duke University, and the University of Minnesota.
Dr Lange has served on many editorial and administrative boards, including that of the New England Journal of Medicine and the American Board of Urology. Dr Lange is internationally recognized for his clinical and research work in a variety of genitourinary cancers, including prostate, testis, bladder and kidney. Of particular note, he helped develop serum markers for testis (AFP, HCG) and prostate (PSA) cancers. While at the University of Minnesota, he helped develop the field of endourology. He is the author of over 400 scientific papers and 3 books. He has trained many people who now are professors or chairmen of urology programs throughout the world. He is founding director emeritus of the Institute for Prostate Cancer Research (IPCF), a world-renowned organization of scientists and physicians at UW Medicine and Fred Hutchinson Cancer Research Center.
Dr Lange has received many national awards for his work including the Huggins Medal, the highest award bestowed by the Society of Urologic Oncology in 2011, in 2014 the Lifetime Achievement Award from the Prostate Cancer Foundation, in 2015 the Distinguished Member Award from the Western American Urology Association (AUA), in 2016 the “Golden Cane Award” from the national AUA for outstanding career achievements, and in 2017 the Keys Medal from the American Association of GU Surgeons, as well as the AUA’s Distinguished Mentor Award for his influence in the development of many academic leaders in urology.
Prof. François Richard, former assistant to professors René Kuss and Maurice Camey, succeeded Christian Chatelain as Head of the Department of Urology at CHU Pitié-Salpétrière, which he led for 12 years.
He served as Chair of the Department of Surgery for 6 years and as Vice President of the Medical Advisory Board, was involved in development of CHU’s hospital and university. He was also a six-year member of the Board of Directors of the Pierre et Marie Curie University. Prof. Richard is a former president of the French Academy of Surgery, and Committee Chair of the French Academy of Medicine. He is currently in charge of the OR Office for the Assistance Publique-Hôpitaux de Paris and the Territorial Reorganization
of Surgery to the Regional Health Agency of the Greater Paris region.
Prof. Richard has authored more than 400 publications, and was the initiator of modern imaging for renal and bladder cancer (CT in 1975, MRI in 1982), the use of the artificial sphincter in women (1982), endourethral prostheses and enlargement enteroplasties in neurourology, as well as the improvement of techniques for conservative surgery of renal tumors in France. With JM Buzelin he transformed urology teaching methods in France. In 1985, he and Guy Vallancien modernized the French Association of Urology (AFU) and were instrumental in the launch of Progress in Urology, which became the leading journal for French-speaking urologists. As a member of the National Council of Universities for 12 years, he created and chaired the "Conference of Medical Sections" to harmonize the conditions for professoral appointments.
He created the Evaluation Committee for new practices and technologies (LEC, laser, thermotherapy, etc.) at AFU, which has conducted numerous national evaluations. Prof. Richard is a member of the executive for several National and International Scientific Societies, and served as SIU Treasurer from 1988 to 1994.
Dr Alex P. Danso is a prominent Ghanaian urologist who has lived and worked in Harare, Zimbabwe since 1984. He received his medical education at the Christian Albrechts University in Kiel, Germany and came to Zimbabwe as Government Consultant Urologist. He joined the Godfrey Huggins School of Medicine Department of Surgery, and served as Department Head from 1987 to 1990.
He remains a passionate advocate for bridging the service gap between the indigent and affluent of Sub-Saharan Africa. He is a fine surgeon and mentor who has impacted the careers of many surgeons and urologists. He has led and participated in numerous outreach programs to many African countries, including Ghana, Zimbabwe, Mozambique, Kenya, and Tanzania.
Dr Danso has spent much time and energy unifying academics and practitioners to find a common goal in pursuing excellence in urology practice and promoting urological education in Africa. Dr Danso is the founder of the Pan African Urological Surgeons’ Association (PAUSA), and is quite rightly considered the father of PAUSA and modern African urology. His vision has formed the backbone of urological education, professional development, and exchanges in Sub-Saharan Africa, and has enabled young surgeons
to advance in the field and anchor training programs of their own.He is an active member of SIU, AUA, PAUSA, COSECSA and a frequent speaker at urology conferences. He continues to conduct research in bladder and prostate cancer, and urethral diseases.
Dr Danso has many publications to his name. He was the President of the Health Professions Council in Zimbabwe and remains a director of several corporate bodies.